Fanconi syndrome associated with didanosine therapy [3]

AIDS

Volumn 19, Issue 8, 2005, Pages 844-845

  Izzedine, Hassane ^a   Launay Vacher, Vincent ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; CREATININE; DIDANOSINE; INDINAVIR; LAMIVUDINE; STAVUDINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LABORATORY TEST; LETTER; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; URINALYSIS;

EID: 20644440634     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000168985.05209.b8     Document Type: Letter

References (7)

1. Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant hepatic failure associated with 2́, 3́-dideoxyinosine (ddl). Ann Intern Med 1991; 115:283-284.
2. Crowther MA, Callaghan W, Hodsman AB, Mackie ID. Dideoxyinosine- associated nephrotoxicity. AIDS 1993; 7:131-132.
3. Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, et al. Adefovir Dipivoxil International 437 Study Group; Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int 2004; 66:1153-1158.
4. Rollot F, Nazal EM, Chauvelot-Moachon L, Kelaidi C, Daniel N, Saba M, et al. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavirdidanosine. Clin Infect Dis 2003; 37:e174-e176.
5. Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, et al. Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 2004; 18:1074-1076.
6. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999; 36:127-143.
7. Navarro JF, Quereda C, Quereda C, Galleeo N, Antela A, Mora C, Ortuno J. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy. Am J Kidney Dis 1996; 27:431-434.